This study performed a genome-wide association study (GWAS) of objectively measured dental caries in permanent dentition among Danish children and adolescents (DCCA). The discovery sample comprised N = 151,521 participants. To extend and test phenotypic and molecular associations, the authors leveraged data from the UK Biobank (Nmax = 501,936) and independent pediatric cohorts (Nmax = 3,412).
Cohort-level ethical approvals and consent procedures were obtained from the National and Zealand Regional Committees on Health Research Ethics and the Danish Data Protection Agency as described in the source. Analytical code for UK Biobank analyses is available in two GitHub repositories cited in the original report.
The GWAS of DCCA identified 14 independent loci associated with dental caries liability in permanent dentition. Genes mapped to these DCCA-associated loci were enriched for expression in specific cell populations relevant to oral biology, notably immune, secretory and epithelial cells. These tissue- and cell-type expression enrichments suggest that genetic influences on caries risk may operate through host immune responses, secretory activity (for example, salivary components) and epithelial barrier or structural functions in the oral cavity.
Analyses reported genetic correlations between DCCA and multiple cardiometabolic traits, and the authors detected evidence for shared causal variants across some loci. These shared genetic signals indicate partial overlap in the genetic architecture of childhood/adolescent dental caries liability and later-life cardiometabolic phenotypes. The source emphasizes that this overlap provides genomic evidence supporting a biological connection between oral health in early life and systemic cardiometabolic outcomes.
Using polygenic liability measures and cross-cohort analyses, the study linked genetic liability to DCCA with multiple adult outcomes in UK Biobank and with molecular biomarkers in both adult and pediatric samples. Specifically, genetic liability to DCCA associated with reported use of dentures, increased risk for coronary artery disease and type 2 diabetes in adults, and quantitative associations with HbA1c, lipid measures, liver enzyme levels and plasma proteins implicated in oral, metabolic and hepatic biology in both populations.
Proteomic associations included plasma proteins that the authors describe as implicated in oral, metabolic or hepatic biology; these molecular links were used to triangulate potential pathways between childhood caries liability and cardiometabolic disease markers. The source presents these integrated genomic–proteomic associations as evidence that genetic predisposition to early-life caries correlates with systemic metabolic and hepatic processes measurable in blood.
The combined genomic and proteomic findings support the view that oral and systemic health are interconnected and that part of this relationship may be explained by shared genetics and downstream molecular signatures. Enrichment of DCCA loci in immune, secretory and epithelial cell populations points to biological mechanisms that could plausibly influence both caries susceptibility (for example, via saliva composition, mucosal immunity or epithelial integrity) and systemic cardiometabolic phenotypes (for example, via inflammatory or metabolic pathways).
The study authors interpret their results as providing new insights into the genetic architecture that underlies relationships between childhood/adolescent dental caries and adult cardiometabolic disease risk. The findings do not on their own establish causality of caries causing cardiometabolic disease but identify shared genetic liability and molecular correlates consistent with mechanistic overlap.
The authors state that GWAS meta-analysis summary statistics will be deposited to the GWAS Catalog upon publication. Individual-level clinical, genomics and proteomics data from the HOLBAEK study cannot be made publicly available due to GDPR restrictions; access can be requested from the corresponding author and requires appropriate approvals from the Danish Data Protection Agency and relevant ethics committees. The source details conditions for data processing and sharing, including requirements for data processing agreements and constraints limiting processing to statistical and scientific research.
Ethical approvals for the contributing cohorts and informed consent procedures are reported in the source. The source publication is a clinical preprint and includes competing interest disclosures for corporate affiliations noted by the authors.
Limitations explicitly reported in the source include data access restrictions for individual-level datasets under GDPR; no additional study limitations, effect sizes or locus-specific details beyond those summarized were reported in the provided source excerpt.